- October 30, 2019
- Heidi Hagen
- Posted in Commercial Scale
Chain of Identity and Chain of Custody in personalized therapies — core differences from traditional pharma
Blog
In pharmaceutical manufacturing, Chain of Identity and Chain of Custody may not be new — but in advanced therapy manufacturing,...
- October 23, 2019
- Vineti
- Posted in Cell and Gene Therapy
Q&A with Dr. Mike Pellini: the need for advanced software to scale cell and gene therapies
Blog
Mike Pellini, M.D., is a member of Vineti’s Board of Directors, a Managing Partner at Section 32, and the former...
- October 17, 2019
- Heidi Hagen
- Posted in Commercial Scale
Supply chain vs. value chain: need-to-know essentials
Blog
In a recent blog post about Quality Risk Management, we talked about the importance of considering the entire “value chain” when...
- October 10, 2019
- Tyler Wilson
- Posted in Cell and Gene Therapy
Design for personalized therapies: reframing “delight” as the goal
Blog
Sometimes, in the world of UX and product design, “delight” means getting out of the way. Read about general approaches...